Aurobindo Pharma Ltd
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition
01 / The disclosure
What the company shared
Intimation of acquisition of a step down subsidiary in USA.
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
Numbers found in document text 1 matches
Automatic text matches, not verified financial metrics. A match may come from a table heading or reporting year. Expand it to inspect the surrounding text and original page.
100%Page 1
This is to inform you that, A1 Biochem USA Inc (“A1 USA Inc”), which is a wholly owned subsidiary of A1 Biochem Labs (India) Private Limited (“A1 Labs India”), has acquired 100% ownership of A1 Biochem Labs LLC (“A1 Labs LLC”) in accordance with the terms of the Definitive Agreements entered into for the acquisition of A1 Biochem Group.
View source pageThe evidence
Read the source excerpts
01We refer to our letters dated July 23, 2026, September 12, 2026 and October 01, 2026, informing that Apitoria Pharma Private Limited ("Apitoria"), a wholly owned subsidiary of the Company , is acquiring the Contract Research Services business of A1 Biochem Group.
Page 1
02This is to inform you that, A1 Biochem USA Inc (“A1 USA Inc”), which is a wholly owned subsidiary of A1 Biochem Labs (India) Private Limited (“A1 Labs India”), has acquired 100% ownership of A1 Biochem Labs LLC (“A1 Labs LLC”) in accordance with the terms of the Definitive Agreements entered into for the acquisition of A1 Biochem Group.
Page 1
03A1 Labs LLC is operating from USA and will now be a step-down subsidiary of A1 Labs India.
Page 1
04ii) Details of the Target: A1 Labs LLC is engaged in providing contract research and chemistry services to pharmaceutical companies, biotechnology companies, including custom synthesis and medicinal chemistry from its scientific laboratory located in Wilmington, North Carolina, USA.
Page 2
05A1 Labs LLC was led by Dr. Rajendra Gadikota , who has 25+ years of experience in this business and shall continue to be employed with A1 Labs LLC after the acquisition.
Page 2
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 7fd3ceaf-f923-41e1-a9f0-acbda7de79f4
- First collected
- 3 Oct 2026, 17:18 IST
- PDF extraction
- extracted · 2 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- 5ab72eae891ee5f89cddaf605d2e4d94ea8421f6006efacb129888089a0cb28a